Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV rebound shows diverse sources, identical virus

Sep. 3, 2019

New selective and potent class I HDAC inhibitor from Merck activates HIV latency ex vivo

Aug. 28, 2019

CytoDyn provides update on its HIV dose-escalating monotherapy trial of leronlimab

Aug. 16, 2019

ZL-0580: a novel BRD4-selective small molecule that suppresses HIV

Aug. 9, 2019

HIV: exosomes potentiate inflammation in bystander cells

Aug. 6, 2019

AAV-eCD4-Ig protects rhesus macaques from SIVmac239 challenges

Aug. 2, 2019

ViiV Healthcare presents week 96 data from ongoing phase III BRIGHTE study

July 29, 2019

Researchers test nanochannel delivery implant for HIV drug cabotegravir

July 26, 2019

TILRR is a new therapeutic target for treating vaginal HIV-1 infection

July 26, 2019

Orion's OB-002 shown to be more potent than maraviroc in a model of HIV infection

July 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...